Principles of Care for the Optimal Management of Systemic Anticancer Therapy-Induced Nausea and Vomiting in the UK
Effective management of nausea and vomiting caused by systemic anticancer therapy (SACT) is essential to maintain patients’ quality of life and ensure treatment success.
Despite existing guidelines, a UK audit revealed significant variation in practice across centres1. To address this, UK oncology experts, in collaboration with Chugai, developed the Principles of Care for the optimal management of SACT-induced nausea and vomiting (SACT-INV).
The principles define five key management areas and ten core principles, providing evidence-based guidance to ensure consistent, high-quality care. Healthcare professionals involved in commissioning and delivering care for people receiving SACT are encouraged to adopt these principles to promote optimal management of SACT-INV and support improved patient outcomes across UK oncology services.
Ref: Martin D., Sladkowski M., UK Wide Audit of Antiemetic Dexamethasone Dosing Given Alongside Highly Emetogenic Chemotherapy [Poster]. British Oncology Pharmacy Association Conference 2024.
The principles of care project was initiated and funded by Chugai Pharma UK Ltd.
Explore the resources below to find out more:
2. Training Deck
Dive deeper into the principles of care with your team using this training deck
Podcast Series
Discover the evolving landscape of supportive oncology care with the Cancer Care Compass, a podcast from Chugai Pharma UK. This edition explores the Principles of Care initiative. Watch the trailer below to learn more
10 Principles. 5 Themes. One goal: consistent supportive care.
Chugai pharma UK Ltd
Disclaimer: The chemo sickness prevention website and materials are created and funded by Chugai pharma UK Ltd for patients and healthcare professionals. Commentary and other materials, including external links, posted on this site are not intended to amount to medical advice on which reliance should be placed. We therefore disclaim all liability and responsibility arising from any reliance placed on such materials by any visitor to our site, or by anyone who may be informed of any of its contents.
This website is designed for and intended to be viewed on a desktop or laptop computer. Copyright © 2025 Chugai pharma UK Ltd. All rights reserved